CCO Treatment Updates

New Classes of Antiretrovirals: The Potential Clinical Role of Integrase Inhibitors and Entry Inhibitors

Virtual Presentation

New Classes of Antiretrovirals: The Potential Clinical Role of Integrase Inhibitors and Entry Inhibitors

Faculty:

Eric S. Daar, MD headshotJoseph J. Eron, Jr., MD headshotDaniel R. Kuritzkes, MD headshot
  • Eric S. Daar, MD
  • Joseph J. Eron, Jr., MD
  • Daniel R. Kuritzkes, MD
John A. Bartlett, MD headshotJoseph Cofrancesco, Jr., MD, MPH, FACP headshotEdwin DeJesus, MD, FACP headshot
  • John A. Bartlett, MD
  • Joseph Cofrancesco, Jr., MD, MPH, FACP
  • Edwin DeJesus, MD, FACP
W. David Hardy, MD headshotRichard Haubrich, MD headshotWilliam A. OBrien, MD, MS headshot
  • W. David Hardy, MD
  • Richard Haubrich, MD
  • William A. O'Brien, MD, MS
Bruce Polsky, MD headshotKimberly Y. Smith, MD, MPH headshotKathleen E. Squires, MD headshot
  • Bruce Polsky, MD
  • Kimberly Y. Smith, MD, MPH
  • Kathleen E. Squires, MD
Pablo Tebas, MD headshotBenjamin Young, MD, PhD headshotAndrew R. Zolopa, MD headshot
  • Pablo Tebas, MD
  • Benjamin Young, MD, PhD
  • Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 06/15/07

Expiration Date: 06/14/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status


Eric S. Daar, MD, discusses new classes of antiretroviral medications in development and their potential ability to improve therapy for HIV-infected patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the need for novel antiretroviral agents
  • Describe recent data on agents in novel classes
  • Identify the clinical settings in which novel antiretroviral agents may find application

New Classes of Antiretrovirals: The Potential Clinical Role of Integrase Inhibitors and Entry Inhibitors


Format: Microsoft PowerPoint (.ppt) | File size: 1,408 KB
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.